Bacterial DNA and replication machinery

Bacterial DNA and its replication machinery constitute a vital set of targets for antimicrobial therapy, encompassing the genomic DNA itself and the enzymes responsible for its duplication and structural maintenance (NCBI, NBK547669). Key components include DNA gyrase and topoisomerase IV, which manage DNA supercoiling and decatenation, as well as DNA polymerases that synthesize new strands (Nature Reviews Microbiology, nrmicro3028). These targets are essential for bacterial cell division and survival, making them ideal for treating a wide range of bacterial infections (PMC, PMC3760480). Drugs such as fluoroquinolones act by stabilizing enzyme-DNA complexes, leading to lethal double-strand breaks, while others like metronidazole cause direct oxidative damage to the DNA structure (PubChem, CID 4173). Because the bacterial replication machinery differs significantly from its eukaryotic counterparts, these targets allow for selective toxicity, although the rapid evolution of resistance mechanisms, such as target site mutations, remains a major clinical concern (Nature Reviews Microbiology, nrmicro3028).

Other names

Bacterial DNA replication systemBacterial replisomeBacterial DNA synthesis machinery

Inhibition of DNA gyrase and topoisomerase IV; direct induction of DNA strand breaks; inhibition of DNA synthesis.